axis healthcare semaglutide Therapy Changes CT Body Composition Axis Prime Medical Institute -

As glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and newer dual- or tri-receptor agonists (incretin mimetics) redefine metabolic health management, oncology clinicians increasingly face questions about their use during and after active cancer treatment

Starting dose is 250mcg

There is seldom a day that goes by where I dont use this product in the morning

I wound up losing more than that

GLP-1 or GLP-1R agonists display a diverse range of physiological functions as shown in the image below

By addressing those needs and their root causes, patients can not only lose weight but make effective changes that maintain weight loss